Pathology of cavernous malformations
- PMID: 28552149
- DOI: 10.1016/B978-0-444-63640-9.00025-4
Pathology of cavernous malformations
Abstract
Cavernous malformations (CMs) are low-pressure angiographically occult lesions, composed of blood-filled sinusoidal locules known as "caverns." Although these lesions were once believed to be congenital in nature, there is compelling evidence to support de novo formation of CMs as well. They can occur as sporadic lesions or be inherited in an autosomal-dominant phenotype in familial forms of the disease. The pathophysiology of CMs is commonly believed to be due to abnormal vascular pathology. Three genes, CCM1, CCM2, and CCM3, have been extensively studied for their role in vascular pathology, resulting in abnormal angiogenesis and compromising the structural integrity of vessel endothelial cell. The expression of growth factors has been researched to gain insight into the dynamic behavior of CM lesions. Gross and microscopic images are utilized in this chapter to illustrate the pathologic findings of these lesions. Ultrastructural analysis demonstrates the aberrations in CM endothelial cells and structural integrity that may provide better understanding into how and why these lesions have a propensity to hemorrhage.
Keywords: angiogenesis; cavernous malformation; epilepsy; pathophysiology; ultrastructural analysis.
© 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.Neurosurg Focus. 2010 Sep;29(3):E1. doi: 10.3171/2010.5.FOCUS1090. Neurosurg Focus. 2010. PMID: 20809750
-
High-throughput sequencing of the entire genomic regions of CCM1/KRIT1, CCM2 and CCM3/PDCD10 to search for pathogenic deep-intronic splice mutations in cerebral cavernous malformations.Eur J Med Genet. 2017 Sep;60(9):479-484. doi: 10.1016/j.ejmg.2017.06.007. Epub 2017 Jun 20. Eur J Med Genet. 2017. PMID: 28645800
-
High-throughput differentiation of human blood vessel organoids reveals overlapping and distinct functions of the cerebral cavernous malformation proteins.Angiogenesis. 2025 Jun 6;28(3):32. doi: 10.1007/s10456-025-09985-5. Angiogenesis. 2025. PMID: 40478324 Free PMC article.
-
Molecular Genetic Features of Cerebral Cavernous Malformations (CCM) Patients: An Overall View from Genes to Endothelial Cells.Cells. 2021 Mar 22;10(3):704. doi: 10.3390/cells10030704. Cells. 2021. PMID: 33810005 Free PMC article. Review.
-
Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.Trends Mol Med. 2013 May;19(5):302-8. doi: 10.1016/j.molmed.2013.02.004. Epub 2013 Mar 15. Trends Mol Med. 2013. PMID: 23506982 Review.
Cited by
-
Circulating biomarkers in familial cerebral cavernous malformation.EBioMedicine. 2024 Jan;99:104914. doi: 10.1016/j.ebiom.2023.104914. Epub 2023 Dec 18. EBioMedicine. 2024. PMID: 38113759 Free PMC article.
-
Long-Term Outcomes of Gamma Knife Radiosurgery for Cerebral Cavernous Malformations: 10 Years and Beyond.J Korean Med Sci. 2024 Aug 19;39(32):e229. doi: 10.3346/jkms.2024.39.e229. J Korean Med Sci. 2024. PMID: 39164054 Free PMC article.
-
Single-cell and bulk RNA-seq unveils the immune infiltration landscape associated with cuproptosis in cerebral cavernous malformations.Biomark Res. 2024 Jun 5;12(1):57. doi: 10.1186/s40364-024-00603-y. Biomark Res. 2024. PMID: 38835051 Free PMC article.
-
Endothelial hyperactivation of mutant MAP3K3 induces cerebral cavernous malformation enhanced by PIK3CA GOF mutation.Angiogenesis. 2023 May;26(2):295-312. doi: 10.1007/s10456-023-09866-9. Epub 2023 Jan 31. Angiogenesis. 2023. PMID: 36719480
-
Temporal Lobe Cavernous Malformation Caused Epileptic Amnesic Episodes and Mild Cognitive Impairment.Front Neurol. 2019 Jun 12;10:620. doi: 10.3389/fneur.2019.00620. eCollection 2019. Front Neurol. 2019. PMID: 31249550 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources